ATE96421T1 - Therapeutische polyaminamide. - Google Patents

Therapeutische polyaminamide.

Info

Publication number
ATE96421T1
ATE96421T1 AT89308741T AT89308741T ATE96421T1 AT E96421 T1 ATE96421 T1 AT E96421T1 AT 89308741 T AT89308741 T AT 89308741T AT 89308741 T AT89308741 T AT 89308741T AT E96421 T1 ATE96421 T1 AT E96421T1
Authority
AT
Austria
Prior art keywords
alkyl
different
cycloalkyl
optionally
substituents
Prior art date
Application number
AT89308741T
Other languages
English (en)
Inventor
Peter Norman Russell Usherwood
Barrie Walsham Bycroft
Ian Stuart Blagbrough
Alan John Mather
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE96421T1 publication Critical patent/ATE96421T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/50Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
AT89308741T 1988-08-30 1989-08-30 Therapeutische polyaminamide. ATE96421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888820442A GB8820442D0 (en) 1988-08-30 1988-08-30 Therapeutic polyamine amides
EP89308741A EP0361687B1 (de) 1988-08-30 1989-08-30 Therapeutische Polyaminamide

Publications (1)

Publication Number Publication Date
ATE96421T1 true ATE96421T1 (de) 1993-11-15

Family

ID=10642872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89308741T ATE96421T1 (de) 1988-08-30 1989-08-30 Therapeutische polyaminamide.

Country Status (9)

Country Link
US (1) US5218000A (de)
EP (1) EP0361687B1 (de)
JP (1) JPH03501022A (de)
AT (1) ATE96421T1 (de)
AU (1) AU629856B2 (de)
DE (1) DE68910259T2 (de)
DK (1) DK105290A (de)
GB (2) GB8820442D0 (de)
WO (1) WO1990002114A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770625A (en) * 1988-02-08 1998-06-23 The Trustees Of Columbia University In The City Of New York Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
US6001824A (en) * 1988-02-08 1999-12-14 The Trustees Of Columbia University Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
DD298412A5 (de) * 1989-04-28 1992-02-20 ������@���Kk�� Verfahren zur herstellung von polypeptiden, die geeignet sind als antagonisten exzitatorischer aminosaeure-neurotransmitter und/oder blocker der calciumkanaele
US5059438A (en) * 1990-02-05 1991-10-22 Enzytech, Inc. Compositions and methods for inhibiting browning in foods using resorcinol derivatives
US5269987A (en) * 1992-12-22 1993-12-14 Reedy Michael E Process for producing alkenyl aromatic foams using a combination of atmospheric and organic gases and foams produced thereby
US5998452A (en) * 1993-06-23 1999-12-07 Chugai Seiyaku Kabushiki Kaisha Benzene derivatives, compositions and methods for treating ischemic diseases
CZ289716B6 (cs) * 1993-06-23 2002-03-13 Chugai Seiyaku Kabushiki Kaisha Léčivo pro léčení ischemických chorob, benzenové deriváty a terapeutické prostředky na jejich bázi
DE69939784D1 (de) * 1998-08-06 2008-12-04 Eidgenoess Tech Hochschule Schmelzverarbeitbares polytetrafluorethylen
ES2161594B1 (es) * 1998-12-17 2003-04-01 Servier Lab Nuevos derivados de la hidrazida, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
TW541295B (en) * 1999-01-05 2003-07-11 Nippon Zoki Pharmaceutical Co A novel substituted alkylteraamine derivative for use as tachykinin antagonist
US6831191B2 (en) 2001-12-20 2004-12-14 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6602515B2 (en) 2001-07-16 2003-08-05 Em Industries Photo stable organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US7273888B2 (en) 2001-11-16 2007-09-25 Als Therapy Development Foundation, Inc. Use of difluoromethylornithine (DFMO) for the treatment of amyotrophic lateral sclerosis
EP1448183A2 (de) * 2001-11-16 2004-08-25 ALS Therapy Development Foundation, Inc. Behandlung von neurodegenerativen erkrankungen durch modulieren des polyaminenbiosynthesewegs
US6699463B2 (en) 2002-04-10 2004-03-02 Em Industries Photostable cationic organic sunscreen compounds with antioxidant properties and compositions obtained therefrom
US6936735B2 (en) * 2002-08-27 2005-08-30 Emd Chemicals, Inc. Photostable cationic organic sunscreen compounds and compositions obtained therefrom
WO2018155260A1 (ja) * 2017-02-23 2018-08-30 株式会社Ihi Ohラジカル検出プローブ、ohラジカル測定装置、および、ohラジカル測定方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB862721A (en) * 1958-06-23 1961-03-15 Miles Lab Dialkylaminoethyl derivatives of salicylamides
GB879957A (en) * 1958-09-22 1961-10-11 Ciba Ltd Improvements relating to the hardening of epoxides
US3272861A (en) * 1961-10-11 1966-09-13 Continental Oil Co Polyalkylene polyamine derivatives of hydroxybenzoic acid
GB1043345A (en) * 1962-02-28 1966-09-21 Minnesota Mining & Mfg Phenolic polyamines
CH448966A (de) * 1965-07-13 1967-09-15 Bayer Ag Verfahren zur Verbesserung der Nassechtheiten von gefärbten textilen Gebilden aus synthetischen Polyamiden
US4172094A (en) * 1976-12-03 1979-10-23 Merck & Co., Inc. Polyamine compounds
US4058624A (en) * 1976-05-14 1977-11-15 Merck & Co., Inc. Broad spectrum antibacterial compositions containing tris (hydroxymethyl)-aminomethane and diphenyl and loweralkyl substituted diphenyl polyamines
GB8419103D0 (en) * 1984-07-26 1984-08-30 Beecham Wuelfing Gmbh & Co Kg Compounds
US5047430A (en) * 1988-04-26 1991-09-10 Takeda Chemical Industries, Ltd. Amide compounds, their production and use
US4990511A (en) * 1988-08-03 1991-02-05 Takeda Chemical Industries, Ltd. Amide compounds, their production and use

Also Published As

Publication number Publication date
GB8919563D0 (en) 1989-10-11
GB2222590B (en) 1992-07-22
JPH03501022A (ja) 1991-03-07
EP0361687B1 (de) 1993-10-27
DK105290D0 (da) 1990-04-27
DE68910259T2 (de) 1994-02-24
AU4192789A (en) 1990-03-23
DK105290A (da) 1990-04-27
US5218000A (en) 1993-06-08
EP0361687A1 (de) 1990-04-04
WO1990002114A1 (en) 1990-03-08
DE68910259D1 (de) 1993-12-02
GB2222590A (en) 1990-03-14
AU629856B2 (en) 1992-10-15
GB8820442D0 (en) 1988-09-28

Similar Documents

Publication Publication Date Title
ATE96421T1 (de) Therapeutische polyaminamide.
NO905572D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
HUP0004529A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk
NO179142C (no) 3-benzyliden-1-karbamoyl-2-pyrrolidon-analoger
YU46497B (sh) Postupak za dobijanje novih derivata pirazola
HUP0004259A2 (hu) VLA-4 által mediált leukocita adhéziót gátló szubsztituált fenilalanin-származékok, ezeket tartalmazó gyógyászati készítmények
IE872588L (en) Compounds
TW249804B (de)
GB1273412A (en) Control of pests with cycloalkane derivatives of nitrated aryl compounds
HUP9900091A2 (hu) Peszticidek
ES347178A1 (es) Procedimiento para la preparacion de nuevas amidas de aci- do.
ES432613A1 (es) Procedimiento para preparar esteres de acidos pirimidintio-notiolfosforicos.
YU72992A (sh) Derivati cikloheksana i tetrahidropirana
DE3866012D1 (de) Antiarrhythmische heilmittel.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
DK0696585T3 (da) Nyt bisoxadiazolidinderivat
ATE38675T1 (de) Phosphatesterderivate und ihre verwendung als anti-krebsmittel.
DE3570249D1 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
WO1991000729A3 (en) Bis-dioxopiperazines, and their use as protecting agents
IE902273L (en) Compositions of 5-phenyl-2-furan esters amides and ketones
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
ES449885A1 (es) Procedimiento para preparar n'-aminoacilaminofenil)-acetami-dinas.
ES8802413A1 (es) Procedimiento para preparar una composicion herbicida a base de carbamoiloxi-fenilcarbamato y aceite mineral de petroleo
EP0292981A3 (en) 2-selenomethyl-1, 4-dihydropyridines a process for the preparation thereof and pharmaceutical compositions containing them
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee